Evidence map›Paper›PMID 26912760›Full record

ReviewJournal of clinical microbiology2016

An Update on the Streptococcus bovis Group: Classification, Identification, and Disease Associations.

John P Dekker, Anna F Lau

Abstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Review
  3. Periprosthetic Joint Infection byLife (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Current understanding of theFrontiers in veterinary science · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Neonatal Sepsis Caused byDiagnostics (Basel, Switzerland) · 2022
    Article
  12. Article
  13. BMJ case reports · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Epidemiology and infection · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

John P DekkerMicrobiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Anna F LauMicrobiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA anna.lau@nih.gov.

Funding

Novel Diagnostic Platforms for Sterility Testing of Cellular Therapies and Biopharmaceutical ProductsZIACL060092 · CLC · CLINICAL CENTER · PI LAU, ANNA · 2014 to 2025
$0k
6 · The paper itself

Abstract

The Streptococcus bovis group has undergone significant taxonomic changes over the past 2 decades with the advent of new identification methods with higher discriminatory power. Although the current classification system is not yet embraced by all researchers in the field and debate remains over the performance of molecular techniques for identification to the species level within the group, important disease associations for several members of the group have been clarified. Here, we provide a brief overview of the history of the S. bovis group, an outline of the currently accepted classification scheme, a review of associated clinical syndromes, and a summary of the performance and diagnostic accuracy of currently available identification methods.

Indexed as

Bacteriological TechniquesHumansMolecular Diagnostic TechniquesStreptococcal InfectionsStreptococcus bovis

Identifiers

PMID26912760
PMCPMC4922088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.